Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-09-15
5:00 pm
Sale
13DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.714,000
1.9%
-1,601,893decrease
(-69.17%)
View
2022-06-07
4:15 pm
Sale
13GCheckmate Pharmaceuticals Inc.
CMPI
venBio Global Strategic Fund II L.P.0
0%
-2,535,158decrease
(Position Closed)
View
2022-05-05
4:15 pm
Sale
13GCheckmate Pharmaceuticals Inc.
CMPI
venBio Global Strategic Fund II L.P.2,535,158
11.5%
-1,138,216decrease
(-30.99%)
View
2022-02-14
2:30 pm
Sale
13GHarmony Biosciences Holdings, Inc.
HRMY
venBio Global Strategic Fund II L.P.2,740,411
4.7%
-764,213decrease
(-21.81%)
View
2021-05-07
4:13 pm
Sale
13DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.2,315,893
6.65%
-352,824decrease
(-13.22%)
View
2021-05-07
1:01 pm
Purchase
13GImpel Pharmaceuticals Inc.
IMPL
venBio Global Strategic Fund II L.P.2,759,791
14.2%
2,759,791increase
(New Position)
View
2021-02-16
4:52 pm
Purchase
13GHarmony Biosciences Holdings, Inc.
HRMY
venBio Global Strategic Fund II L.P.3,504,624
6.2%
3,504,624increase
(New Position)
View
2020-10-06
3:19 pm
Purchase
13GCheckmate Pharmaceuticals Inc.
CMPI
venBio Global Strategic Fund II L.P.3,673,374
17.1%
3,673,374increase
(New Position)
View
2020-10-01
10:01 am
Purchase
13DALX Oncology Holdings Inc.
ALXO
venBio Global Strategic Fund II L.P.9,799,331
26.9%
9,799,331increase
(New Position)
View
2020-09-09
5:26 pm
Sale
13DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.2,668,717
7.7%
-653,421decrease
(-19.67%)
View
2020-04-16
12:47 pm
Sale
13DVYNE Therapeutics Inc.
MNLO
venBio Global Strategic Fund II L.P.0
0%
-1,461,552decrease
(Position Closed)
View
2020-01-15
4:27 pm
Sale
13DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.3,322,138
11.6%
-632,720decrease
(-16.00%)
View
2019-06-26
4:20 pm
Purchase
13DAkero Therapeutics, Inc.
AKRO
venBio Global Strategic Fund II L.P.3,954,858
14.17%
3,954,858increase
(New Position)
View
2019-02-14
08:50 am
Sale
13GApellis Pharmaceuticals, Inc.
APLS
venBio Global Strategic Fund II L.P.1,790,102
3.2%
-1,789,203decrease
(-49.99%)
View
2019-02-14
08:49 am
Sale
13GNabriva Therapeutics plc
NBRV
venBio Global Strategic Fund II L.P.0
0%
-2,122,962decrease
(Position Closed)
View